Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Octreoscan

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 159201-00-0, Indium in 111 pentetreotide [usan], 2-[2-[[2-[[1-[[10-(4-aminobutyl)-16-benzyl-4-(1,3-dihydroxybutan-2-ylcarbamoyl)-7-(1-hydroxyethyl)-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-(carboxylatomethyl)amino]ethyl-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;hydron;indium(3+), Octreoscan (tn), Indium in 111 pentetreotide (usp), Indate(1-), (n-(2-((2-(bis(carboxymethyl)amino)ethyl)(carboxymethyl)amino)ethyl)-n-(carboxymethyl)glycyl-d-phenylalanyl-l-cysteinyl-l-phenylalanyl-d-tryptophyl-l-lysyl-l-threonyl-n-(2-hydroxy-1-(hydroxymethyl)propyl)-l-cysteinamide cyclic (3-8)-disulfidato(4-))-, hydrogen, (r-(r*,r*))-
    Molecular Formula
    C63H84InN13O19S2
    Molecular Weight
    1506.4  g/mol
    InChI Key
    ONJXCGCIKIYAPL-UHFFFAOYSA-K
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    2-[2-[[2-[[1-[[10-(4-aminobutyl)-16-benzyl-4-(1,3-dihydroxybutan-2-ylcarbamoyl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-(carboxylatomethyl)amino]ethyl-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;hydron;indium(3+)
    2.1.2 InChI
    InChI=1S/C63H87N13O19S2.In/c1-37(78)48(34-77)70-62(94)50-36-97-96-35-49(71-58(90)45(25-39-13-5-3-6-14-39)66-51(80)29-75(31-53(83)84)23-21-74(30-52(81)82)22-24-76(32-54(85)86)33-55(87)88)61(93)68-46(26-40-15-7-4-8-16-40)59(91)69-47(27-41-28-65-43-18-10-9-17-42(41)43)60(92)67-44(19-11-12-20-64)57(89)73-56(38(2)79)63(95)72-50;/h3-10,13-18,28,37-38,44-50,56,65,77-79H,11-12,19-27,29-36,64H2,1-2H3,(H,66,80)(H,67,92)(H,68,93)(H,69,91)(H,70,94)(H,71,90)(H,72,95)(H,73,89)(H,81,82)(H,83,84)(H,85,86)(H,87,88);/q;+3/p-3
    2.1.3 InChI Key
    ONJXCGCIKIYAPL-UHFFFAOYSA-K
    2.1.4 Canonical SMILES
    [H+].CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)NC(=O)CN(CCN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])C(=O)NC(CO)C(C)O)O.[In+3]
    2.2 Synonyms
    2.2.1 MeSH Synonyms

    1. 111 In -pentetreotide

    2. 111-indium-pentetreotide

    3. In-111 Pentetreotide

    4. Indium Ln-111 Pentetreotide

    5. Indium-pentetreotide

    6. Octreoscan

    7. Octreoscan 111

    8. Pentetreotide

    2.2.2 Depositor-Supplied Synonyms

    1. 159201-00-0

    2. Indium In 111 Pentetreotide [usan]

    3. 2-[2-[[2-[[1-[[10-(4-aminobutyl)-16-benzyl-4-(1,3-dihydroxybutan-2-ylcarbamoyl)-7-(1-hydroxyethyl)-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-(carboxylatomethyl)amino]ethyl-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;hydron;indium(3+)

    4. Octreoscan (tn)

    5. Indium In 111 Pentetreotide (usp)

    6. Indate(1-), (n-(2-((2-(bis(carboxymethyl)amino)ethyl)(carboxymethyl)amino)ethyl)-n-(carboxymethyl)glycyl-d-phenylalanyl-l-cysteinyl-l-phenylalanyl-d-tryptophyl-l-lysyl-l-threonyl-n-(2-hydroxy-1-(hydroxymethyl)propyl)-l-cysteinamide Cyclic (3-8)-disulfidato(4-))-, Hydrogen, (r-(r*,r*))-

    7. 139096-04-1

    8. D02108

    2.3 Create Date
    2005-08-09
    3 Chemical and Physical Properties
    Molecular Weight 1506.4 g/mol
    Molecular Formula C63H84InN13O19S2
    Hydrogen Bond Donor Count14
    Hydrogen Bond Acceptor Count25
    Rotatable Bond Count30
    Exact Mass1505.4486636 g/mol
    Monoisotopic Mass1505.4486636 g/mol
    Topological Polar Surface Area556 Ų
    Heavy Atom Count98
    Formal Charge0
    Complexity2570
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count10
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count3
    4 Drug and Medication Information
    4.1 Drug Information
    1 of 2  
    Drug NameOctreoscan
    PubMed HealthIndium In 111 Pentetreotide (Injection)
    Drug ClassesDiagnostic Agent, Radiopharmaceutical Imaging
    Active IngredientIndium in-111 pentetreotide kit
    Dosage FormInjectable
    RouteInjection
    Strength3mci/ml
    Market StatusPrescription
    CompanyMallinckrodt

    2 of 2  
    Drug NameOctreoscan
    PubMed HealthIndium In 111 Pentetreotide (Injection)
    Drug ClassesDiagnostic Agent, Radiopharmaceutical Imaging
    Active IngredientIndium in-111 pentetreotide kit
    Dosage FormInjectable
    RouteInjection
    Strength3mci/ml
    Market StatusPrescription
    CompanyMallinckrodt